Cargando…

[(18)F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

BACKGROUND: Immune checkpoint inhibitors have changed the paradigm of cancer treatment; however, non-invasive biomarkers of response are still needed to identify candidates for non-responders. We aimed to investigate whether immunotherapy [(18)F]FDG PET radiomics signature (iRADIOMICS) predicts resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valentinuzzi, Damijan, Vrankar, Martina, Boc, Nina, Ahac, Valentina, Zupancic, Ziga, Unk, Mojca, Skalic, Katja, Zagar, Ivana, Studen, Andrej, Simoncic, Urban, Eickhoff, Jens, Jeraj, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409607/ https://www.ncbi.nlm.nih.gov/pubmed/32726293 http://dx.doi.org/10.2478/raon-2020-0042

Ejemplares similares

Immune RECIST Criteria and Symptomatic Pseudoprogression in Non-small Cell Lung Cancer Patients Treated with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
por: Hribernik, Nežka, et al.
Publicado: (2021)

The Dose Accumulation and The Impact of Deformable Image Registration on Dose Reporting Parameters in a Moving Patient Undergoing Proton Radiotherapy
por: Razdevsek, Gasper, et al.
Publicado: (2022)

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
por: Colen, Rivka R, et al.
Publicado: (2021)

CT based radiomic approach on first line pembrolizumab in lung cancer
por: Zerunian, Marta, et al.
Publicado: (2021)

Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
por: Cunha, Mateus Trinconi, et al.
Publicado: (2021)

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies
por: Kendrick, Jake, et al.
Publicado: (2021)

Radiomics Features Differentiate Between Normal and Tumoral High-Fdg Uptake
por: Hsu, Chih-Yang, et al.
Publicado: (2018)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

The Impact of Artificial Intelligence CNN Based Denoising on FDG PET Radiomics
por: Jaudet, Cyril, et al.
Publicado: (2021)

Radiomics–clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma
por: Ding, Jianming, et al.
Publicado: (2023)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges
por: Peng, Shichun, et al.
Publicado: (2020)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

AutoRadiomics: A Framework for Reproducible Radiomics Research
por: Woznicki, Piotr, et al.
Publicado: (2022)

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
por: van Timmeren, Janna E., et al.
Publicado: (2019)

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
por: Pavic, M., et al.
Publicado: (2020)

Quantitative accuracy of radiomic features of low-dose (18)F-FDG PET imaging
por: Gao, Xin, et al.
Publicado: (2020)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques
por: Abenavoli, Elisabetta Maria, et al.
Publicado: (2023)

Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey
por: Volpe, Stefania, et al.
Publicado: (2023)

Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics
por: Aide, Nicolas, et al.
Publicado: (2018)

Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery
por: Ansquer, Catherine, et al.
Publicado: (2020)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer
por: Amrane, Karim, et al.
Publicado: (2023)

Prognostic (18)F-FDG Radiomic Features in Advanced High-Grade Serous Ovarian Cancer
por: Travaglio Morales, Daniela, et al.
Publicado: (2023)

Radiomics for liver tumours
por: Dreher, Constantin, et al.
Publicado: (2020)

Radiomics in Nasopharyngeal Carcinoma
por: Duan, Wenyue, et al.
Publicado: (2022)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

Radiomics in Oncology III
por: Zerunian, Marta, et al.
Publicado: (2023)

Radiomics in the diagnosis of glioblastoma
por: Kwiatkowska-Miernik, Agnieszka, et al.
Publicado: (2023)

Radiomics Analysis for Multiple Myeloma: A Systematic Review with Radiomics Quality Scoring
por: Klontzas, Michail E., et al.
Publicado: (2023)

The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
por: Leijenaar, Ralph T.H., et al.
Publicado: (2015)

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Radiomic analysis for predicting prognosis of colorectal cancer from preoperative (18)F-FDG PET/CT
por: Lv, Lilang, et al.
Publicado: (2022)

Exploring the Utility of Radiomic Feature Extraction to Improve the Diagnostic Accuracy of Cardiac Sarcoidosis Using FDG PET
por: Mushari, Nouf A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9o503v0eor08tsmm7c5fbgskp8